Third “Biologie Prospective” Santorini Conference
Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease1
Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients1
Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)1
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome1
Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome1
Interleukin-6 gene promoter-174G/C polymorphism and insulin resistance
Apolipoprotein E polymorphism-a risk factor for metabolic syndrome1
Peripheral blood mononuclear cells (PBMCs)
New perspectives and strategy research biomarkers for hepatocellular carcinoma
Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification
The uncoupling protein-1 gene −3826A/G polymorphism and hypertension in Japanese subjects
Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia
Histamine induces the expression of uncoupling protein 2 (UCP2) and acid-binding protein (aP2) in white adipocytes
Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients
Reliability of oxidative stress biomarkers in hemodialysis patients
The association between lipid profiles and breast cancer among Taiwanese women
Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders
Short communication
Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population
Intra-individual variation in creatinine and cystatin C
Gammopathy interference in clinical chemistry assays
An Italian program of External Quality Control for chromogranin A (CgA) assay
Automated urinalysis
Type B natriuretic peptide stability in frozen plasma
THE PRESENT AND FUTURE OF LABORATORY MEDICINE
HOW TO MANAGE A PATIENT WITH A MONOCLONAL GAMMOPATHY. THE ROLE OF THE SPECIALIST IN INTERNAL MEDICINE
THE ROLE OF THE CLINICAL CHEMISTRY LABORATORY IN THE DIAGNOSIS AND MANAGEMENT OF MONOCLONAL GAMMAPATHIES
MONOCLONAL GAMMOPATHY AND THE KIDNEY
MONOCLONAL COMPONENTS AND CONTRAST MEDIA
THE GLYCEMIC CONTROL IN DIABETES
SELF-MONITORING OF BLOOD GLUCOSE (SMBG) IN DIABETES PATIENTS, INSTRUMENT QUALITY AS WELL AS CLINICAL UTILITY
SCREENING AND DIAGNOSIS OF GESTATIONAL DIABETES AFTER THE APO STUDY
DIABETES AND COAGULATION
EFFECT OF PHYSICAL ACTIVITY ON HIGH-SENSITIVITY C-REACTIVE PROTEIN (HS-CPR), IL-6, IL10 AND TNF-ALFA SERUM LEVELS IN TYPE 2 DIABETES MELLITUS (T2DM) SUBJECTS WITH METABOLIC SYNDROME (MTS)
IS THE PLATELET SIZE ACTUALLY A RISK INDEX OF VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES?
EFFECTOR CELLS AND MEDIATORS OF FOOD ALLERGY
DIAGNOSTIC TESTS IN VITRO AND UNPROVEN DIAGNOSTIC PROCEDURES
FOOD ALLERGENS AND MOLECULAR DIAGNOSIS
CLINICAL VALUE OF FOOD-SPECIFIC lgG4 ANTIBODIES
BIOCHEMISTRY AND PHYSIOPATHOLOGY OF BONE TISSUE
POSTMENOPAUSAL OSTEOPOROSIS
GLUCOCORTICOID-INDUCED OSTEOPOROSIS
TRADITIONAL AND NEW INFORMATION FROM THE BONE BIOCHEMICAL MARKERS ASSESSMENT
THE BIOLOGICAL VARIABILITY IS CRUCIAL PART OF THE ANALYTICAL VARIABILITY
PREANALYTICAL VARIABILITY IN COAGULATION TESTING
TRANSFERABILITY OF LABORATORY DATA AND STANDARDIZATION OF PREANALYTICAL VARIABLES
QUALITY INDICATORS IN THE EXTRA-ANALYTICAL PHASE
REORGANIZATION OF CLINICAL LABORATORY BY CENTRALIZATION
INFLUENCE OF STORAGE TEMPERATURE ON ROUTINE COAGULATION TESTING
CREATININE MEASUREMENT AND GLOMERULAR FILTRATION RATE ESTIMATION
LABORATORY CONTRIBUTION
LABORATORY CONTRIBUTION
ACCURACY IMPROVEMENT OF CREATININE MEASUREMENT BY USE OF AN ENZYMATIC ASSAY
PROGNOSTIC VALUE OF COMBINED USE OF B-TYPE NATRIURETIC PEPTIDES AND INTERLEUKIN-6 IN PREDICTING CARDIAC MORTALITY IN END-STAGE RENAL DISEASE PATIENTS
ORGANISATION OF THE “PROTEIN LAB”
INTEGRATION BETWEEN CORE-LAB AND WITHIN-HOSPITAL AND TERRITORIAL POINTS-OF-CARE IN THE DIAGNOSIS OF EMERGENCY CARDIOLOGY
AN AUTOMATION EXPERIENCE IN MOLECULAR BIOLOGY
POTENTIAL APPLICATION OF REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTION-PCR FOR HER2 DETECTION IN PERIPHERAL BLOOD FROM BREAST CANCER PATIENTS
TRAINING OF LABORATORY MEDICINE PROFESSIONALS
REFERENCE INFORMATION MODEL FOR CLINICAL LABORATORIES
INFORMATION TECHNOLOGY FOR PERSONALIZED MEDICINE
INFORMATION TECHNOLOGY IN THE DIAGNOSTIC APPROPRIATENESS EVALUATION
INFORMATION TECHNOLOGY AND APPROPRIATE USE OF DIAGNOSTIC TEST
WEBCOMMUNITY PILOT PROJECT
EUROPEAN NETWORK FOR RARE AND CONGENITAL ANAEMIAS (ENERCA) THE SECOND PHASE
SMART DRUGS
ON SITE DRUG TESTING
LEGAL-MEDICAL COMMISSIONS
PROFESSIONAL LIABILITIES OF THE CLINICAL AND FORENSIC TOXICOLOGIST IN ADMINISTRATIVE AND CIVIL CERTIFICATION
SUGGESTIONS CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) MEASUREMENT IN FORENSIC USE AND A TRAFFIC SAFETY CONTEXT
DRUG MONITORING IN BREAST MILK